Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001104659-26-112065

Chief Medical Officer sold 10,853 shares at $36.57 ($396,894)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Karlin Daniel · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-25 Sale : show line 1 in the form 10b5-1 −10,853 $36.57 $396,894 792,846 D
Open-market sales · 10,853 sh · avg $36.57 · $396,894
Loading xslF345X06/tm2626627-5_4seq1.xml…